MELISSA JAEGER: Open Payments
NPI 1306508635 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 87 payments from 15 companies in 2025. Trend: 2023 $1,934 · 2024 $1,533 · 2025 $1,474
Food & beverage: $1,364Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $395 |
| Janssen Biotech, Inc. | 13 | $228 |
| UCB, Inc. | 13 | $169 |
| Lilly USA, LLC | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. | 8 | $142 |
| Galderma Laboratories, L.P. | 5 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Arcutis Biotherapeutics, Inc. | 2 | $28 |
Products named: SKYRIZI, TREMFYA, Bimzelx, RINVOQ, DUPIXENT, TALTZ, ILUMYA, EBGLYSS.
Industry payments across WA — which companies pay providers there.
